JUNE Medical Announces the Launch of a Male Surgical Retractor Kit

October 13, 2020

JUNE Medical is expanding its comprehensive portfolio of medical devices with the upcoming launch of its new pre-packed retractor kits, especially for male procedures. Based on the company’s award-winning Galaxy II retractor, the Galaxy II Male kit brings the same level of innovation to male surgeries.

June Medical notes the Galaxy II Male kit is set to revolutionize male procedures by dramatically improving visualization during surgery. This straightforward and easy to use kit is suitable for a wide range of procedures requiring optimal control over the surgical site, such as scrotal and associated surgeries, as well as prosthetic testicle implantations. The kit features a number of different accessories and a novel hammock elevation strap to maneuver the male anatomy, allowing the penis to be held securely without requiring hooks through the skin, improving patient comfort.

The kit also benefits from all of the characteristics that have made the Galaxy II system so popular. The retractor’s unique, design-protected cam locks allow simple single-handed adjustment for rapid repositioning, while the slots on the retractor ring easily secure the stays in place. Together with a range of stay hooks designed to enable high tension without the risk of tissue tearing, this system provides an innovative, cost-effective, and convenient solution for a wide range of surgical procedures.

Angela Spang, CEO of JUNE Medical, commented: “The Galaxy II frees up the hands of assistants and nurses that often have to hold the retractor, sometimes for long periods of time. This improves efficiency and reduces the number of people needed in the operating room, which is especially useful during the COVID-19 pandemic to help reduce infection risk.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”